Founded in 2018 by Guido Magrin and Luca Iozzia, TeiaCare develops advanced monitoring solutions for residential healthcare facilities such as nursing homes, rehabilitation centres, and dementia care ...
Rivia has developed the first reusable intelligence layer for clinical trials. Its data engine integrates thousands of heterogeneous files in real time, applies trial-specific scientific logic using i...
Navidence offers AI-native technology and professional services that make it radically easier to design and deploy clinical research studies using RWD. The company's platform develops Computable Opera...
This investment aligns with Nina Capital’s mission of supporting technologies that improve care delivery workflows and financial integrity across critical and resource-constrained areas of healthcar...
LillianCare tackles a growing challenge in Germany: by 2035, there will be a shortage of 11,000 general practitioners, particularly in rural areas. Its hybrid practice model combines interdisciplinary...
Datamonk uses agentic AI to automate PACS migrations and improve data quality along the way. Its software agents detect and fix metadata issues, standardise study naming, and validate data integrity w...
Over 100 laboratories, including prestigious institutions like Johns Hopkins, UCSF, Harvard, and UCL, are already using DataJoint. By automating data structuring, processing, and analysis, the platfor...
The funding round was led by aMoon, Israel’s largest dedicated HealthTech investment fund, and saw participation from existing investors including Norgine Ventures BV, Nina Capital, Namarel Ventures...
With Fund III, Nina Capital is set to build a new portfolio of investments across Europe, North America, Israel, and, for the first time, Australia. From pre-seed to Series A, the fund will write init...
Nina Capital and Caesar led the extension, highlighting their ongoing commitment to LillianCare's vision. This round also welcomed several new investors, including Ship2B Ventures (through the BSocial...
Nina Capital, an emerging specialist venture capital firm, today announced its second fund, started last fall, eclipsed its target size of EUR40 million in just four months. The fund will be used to c...
Nina Capital ha superado el objetivo inicial de 15 millones de euros para su primer vehículo de inversión en apenas cuatro meses. La gestora de capital riesgo especializada en salud digital, con sed...